RhumbLine Advisers’s Lyra Therapeutics LYRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,754
| Closed | -$11K | – | 4211 |
|
|
2025
Q1 | $11K | Buy |
1,754
+929
| +113% | +$5.85K | ﹤0.01% | 3822 |
|
|
2024
Q4 | $8.5K | Hold |
825
| – | – | ﹤0.01% | 3898 |
|
|
2024
Q3 | $10.6K | Sell |
825
-43
| -5% | -$552 | ﹤0.01% | 3881 |
|
|
2024
Q2 | $12K | Buy |
868
+862
| +14,367% | +$11.9K | ﹤0.01% | 3953 |
|
|
2024
Q1 | $1.84K | Hold |
6
| – | – | ﹤0.01% | 4096 |
|
|
2023
Q4 | $1.55K | Hold |
6
| – | – | ﹤0.01% | 4116 |
|
|
2023
Q3 | $1.16K | Hold |
6
| – | – | ﹤0.01% | 4168 |
|
|
2023
Q2 | $1.22K | Buy |
+6
| New | +$1.22K | ﹤0.01% | 4271 |
|